Novel Targeted Approaches to the Contemporary Management of Migraine

A comprehensive educational program including a faculty-led interactive video roundtable plus 2 ClinicalThought expert commentaries and downloadable slides.
Jessica Ailani, MD
Robert G. Kaniecki, MD

ClinicalThought

My reflection on how far we’ve come in improving the treatment of acute and chronic migraine, from triptans and beta-blockers to small molecules and monoclonal antibodies that target CGRP.

Robert G. Kaniecki, MD Released: March 26, 2020

My take on real-world successes, challenges, and ongoing questions on the use of monoclonal antibodies that target CGRP for migraine prophylaxis.

Jessica Ailani, MD Released: April 9, 2020
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Allergan
Amgen
Lundbeck

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue